Vaginitis in a gynecologic practice in Israel: causes and risk factors.
BACKGROUND
Vaginal symptoms are a leading reason for a patient to visit her gynecologist. Little is known about the prevalence of the different causes of vaginitis and the risk factors for this entity in Israel.


OBJECTIVE
To determine the prevalence of the main forms of vaginitis: vulvovaginal candidiasis, bacterial vaginosis, and trichomoniasis, in a gynecologic practice in Israel.


METHODS
We evaluated 208 patients presenting with vaginal symptoms to a gynecologic clinic; 100 asymptomatic women who attended the clinic for routine check-up served as controls. Demographic, medical and gynecologic histories were obtained, and a pelvic examination was performed in all patients. Vaginal specimens were tested for pH and amine reaction, smeared for Gram-staining and cultured for yeasts and Trichomonas vaginalis. Bacterial vaginitis was diagnosed using the Nugent scoring system. Candida infection was diagnosed by microscopic examination and by culture.


RESULTS
Candida spp. was the most common pathogen, documented by microscopy and culture in 35.5% of symptomatic women and 15% of asymptomatic controls (P < 0.001). Detection by culture only (negative microscopy) was documented in 18.7% of symptomatic patients and 15% of controls (P = 0.5). Bacterial vaginosis (Nugent score > or = 7) was diagnosed in 23.5% of patients and 13% of controls (P = 0.04). Trichomoniasis was present in 8.1% of symptomatic women and 4% of controls (P = 0.1). The main risk factors were antibiotic use for candidiasis and lack of use of oral contraception and condom use for trichomoniasis.


CONCLUSIONS
Candida was by far the most common pathogen detected in our population. A statistically significant difference between patients and controls was noted for the prevalence of microscopically diagnosed candidiasis and bacterial vaginosis.
D000328:Adult; D017677:Age Distribution; D000554:Ambulatory Care Facilities / Q000706:statistics & numerical data*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002175:Candida / Q000302:isolation & purification; D002181:Candidiasis, Vulvovaginal / Q000453:epidemiology; D015984:Causality; D002690:Chlamydia Infections / Q000453:epidemiology; D003268:Contraception Behavior / Q000706:statistics & numerical data; D005260:Female; D006069:Gonorrhea / Q000453:epidemiology; D006176:Gynecology / Q000706:statistics & numerical data*; D006801:Humans; D007557:Israel / Q000453:epidemiology; D015995:Prevalence; D012016:Reference Values; D012307:Risk Factors; D014247:Trichomonas Vaginitis / Q000453:epidemiology; D014621:Vagina / Q000382:microbiology; D014627:Vaginitis / Q000453:epidemiology*; D016585:Vaginosis, Bacterial / Q000453:epidemiology
D000900:Anti-Bacterial Agents